Trading Report: Today, Quantbot Technologies LP Invests $164,000 in Analogic Corp. (ALOG)

Today, Quantbot Technologies LP Invests $164,000 in Analogic Corp. (ALOG)

Quantbot Technologies LP purchased a new position in Analogic Corp. (NASDAQ:ALOG) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 1,855 shares of the company’s stock, valued at approximately $164,000.

Several other hedge funds also recently added to or reduced their stakes in the company. Royce & Associates LP increased its stake in Analogic Corp. by 2.5% in the second quarter. Royce & Associates LP now owns 580,101 shares of the company’s stock worth $46,083,000 after buying an additional 14,400 shares during the period. Dynamic Technology Lab Private Ltd bought a new stake in Analogic Corp. during the second quarter worth approximately $260,000. Goldman Sachs Group Inc. increased its stake in Analogic Corp. by 9.9% in the first quarter. Goldman Sachs Group Inc. now owns 15,038 shares of the company’s stock worth $1,188,000 after buying an additional 1,351 shares during the period. Victory Capital Management Inc. increased its stake in Analogic Corp. by 3.6% in the second quarter. Victory Capital Management Inc. now owns 156,219 shares of the company’s stock worth $12,410,000 after buying an additional 5,440 shares during the period. Finally, Silvercrest Asset Management Group LLC increased its stake in Analogic Corp. by 12.2% in the second quarter. Silvercrest Asset Management Group LLC now owns 656,052 shares of the company’s stock worth $52,116,000 after buying an additional 71,192 shares during the period.

Analogic Corp. (NASDAQ:ALOG) traded up 1.11% during mid-day trading on Friday, hitting $95.30. 27,242 shares of the company were exchanged. The stock has a market cap of $1.18 billion, a P/E ratio of 99.27 and a beta of 0.79. The company has a 50 day moving average of $85.89 and a 200 day moving average of $85.20. Analogic Corp. has a 12-month low of $68.71 and a 12-month high of $95.58.

Analogic Corp. (NASDAQ:ALOG) last announced its quarterly earnings results on Wednesday, September 21st. The company reported $1.02 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.17 by $0.15. The business earned $138.10 million during the quarter, compared to the consensus estimate of $139.03 million. Analogic Corp. had a net margin of 2.38% and a return on equity of 7.33%. The company’s quarterly revenue was down 10.6% compared to the same quarter last year. During the same period last year, the firm earned $1.28 EPS. On average, equities research analysts expect that Analogic Corp. will post $4.04 earnings per share for the current fiscal year.

A number of analysts have commented on ALOG shares. Brean Capital restated a “buy” rating and set a $100.00 price target (up from $90.00) on shares of Analogic Corp. in a research report on Thursday, September 22nd. Zacks Investment Research downgraded shares of Analogic Corp. from a “hold” rating to a “sell” rating in a report on Tuesday, September 27th.

In other news, insider James Patrick Ryan sold 546 shares of the company’s stock in a transaction dated Thursday, September 15th. The shares were sold at an average price of $88.19, for a total value of $48,151.74. Following the sale, the insider now owns 1,800 shares of the company’s stock, valued at approximately $158,742. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Shalabh Chandra sold 2,650 shares of the company’s stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $90.00, for a total transaction of $238,500.00. Following the completion of the sale, the insider now directly owns 5,967 shares in the company, valued at approximately $537,030. The disclosure for this sale can be found here. 2.40% of the stock is currently owned by company insiders.

About Analogic Corp.

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies to advance the practice of medicine and save lives. The Company operates through three business segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.

Related posts

Leave a Comment